Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


17.09.2018

1 Ann Oncol
1 Ann Surg Oncol
6 Anticancer Res
2 BMC Cancer
2 Breast Cancer
1 Breast Cancer Res
4 Breast Cancer Res Treat
1 Cancer Epidemiol Biomarkers Prev
3 Clin Breast Cancer
1 Eur J Cancer
2 Int J Cancer
1 Int J Radiat Oncol Biol Phys
1 J Clin Invest
1 J Clin Oncol
1 J Surg Oncol
2 Lancet Oncol
1 Nat Rev Clin Oncol
2 NPJ Breast Cancer
1 Oncogene
4 PLoS One
1 Proc Natl Acad Sci U S A
1 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. SZEKELY B, Bossuyt V, Li X, Wali VB, et al
    Immunological differences between primary and metastatic breast cancer.
    Ann Oncol. 2018 Sep 10. pii: 5094494. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  2. LANDERCASPER J
    Correction to: Why Do Reoperation Rates Vary So Much After Lumpectomy for Breast Cancer? Examining the Reoperation Puzzle.
    Ann Surg Oncol. 2018 Sep 10. pii: 10.1245/s10434-018-6748.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. ZHOU M, Peddi P, Chu QD
    Radiation Therapy for Positive Surgical Margins in Women >/=70 Years with Stage I, Estrogen Receptor-positive Breast Cancer.
    Anticancer Res. 2018;38:5253-5260.
    PubMed     Text format     Abstract available

  4. LEBLANC N, Harquail J, Crapoulet N, Ouellette RJ, et al
    Pax-5 Inhibits Breast Cancer Proliferation Through MiR-215 Up-regulation.
    Anticancer Res. 2018;38:5013-5026.
    PubMed     Text format     Abstract available

  5. WILHELM CA, Clor ZJ, Kelts JL
    Effect of Vitamin D on Paclitaxel Efficacy in Triple-negative Breast Cancer Cell Lines.
    Anticancer Res. 2018;38:5043-5048.
    PubMed     Text format     Abstract available

  6. JOO JH, Kim SS, Son BH, DO Ahn S, et al
    Evaluation of the Prognostic Stage in the 8th Edition of the American Joint Committee on Cancer in Patients with Breast Cancer and Internal Mammary Lymph Node Metastasis.
    Anticancer Res. 2018;38:5357-5361.
    PubMed     Text format     Abstract available

  7. NAKATSUKASA K, Ouchi Y, Sakaguchi K, Goto M, et al
    Dynamic Contrast-enhanced Magnetic Resonance Imaging for Patients with Breast Cancer Receiving First-line Bevacizumab and Paclitaxel.
    Anticancer Res. 2018;38:5459-5463.
    PubMed     Text format     Abstract available

  8. BONZANO E, Belgioia L, Fregatti P, Friedman D, et al
    Tumor Size-driven Dose of Intraoperative Radiotherapy for Breast Cancer: 18 Gy Versus 21 Gy.
    Anticancer Res. 2018;38:5475-5479.
    PubMed     Text format     Abstract available


    BMC Cancer

  9. VENTURELLI E, Orenti A, Fabricio ASC, Garrone G, et al
    Correction to: Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients.
    BMC Cancer. 2018;18:876.
    PubMed     Text format     Abstract available

  10. XIONG Z, Deng G, Wang J, Li X, et al
    Could local surgery improve survival in de novo stage IV breast cancer?
    BMC Cancer. 2018;18:885.
    PubMed     Text format     Abstract available


    Breast Cancer

  11. GLOWACKA-MROTEK I, Sowa M, Nowikiewicz T, Siedlecki Z, et al
    Foot posture in female patients 5 years after breast-conserving surgery: a case-control study.
    Breast Cancer. 2018;25:325-333.
    PubMed     Text format     Abstract available

  12. KIKAWA Y, Hatachi Y, Rumpold G, Tokiwa M, et al
    Evaluation of health-related quality of life via the Computer-Based Health Evaluation System (CHES) for Japanese metastatic breast cancer patients: a single-center pilot study.
    Breast Cancer. 2018 Sep 7. pii: 10.1007/s12282-018-0905.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  13. GAO P, Wang X, Jin Y, Hu W, et al
    Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells.
    Breast Cancer Res. 2018;20:112.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  14. TAKADA M, Sugimoto M, Masuda N, Iwata H, et al
    Prediction of postoperative disease-free survival and brain metastasis for HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab using a machine learning algorithm.
    Breast Cancer Res Treat. 2018 Sep 7. pii: 10.1007/s10549-018-4958.
    PubMed     Text format     Abstract available

  15. PEREZ-PENA J, Gyorffy B, Amir E, Pandiella A, et al
    Epigenetic modulation of FOXM1-gene interacting network by BET inhibitors in breast cancer.
    Breast Cancer Res Treat. 2018 Sep 11. pii: 10.1007/s10549-018-4965.
    PubMed     Text format     Abstract available

  16. JEON SH, Shin KH, Kim JH, Kim K, et al
    Effects of trastuzumab on locoregional recurrence in human epidermal growth factor receptor 2-overexpressing breast cancer patients treated with chemotherapy and radiotherapy.
    Breast Cancer Res Treat. 2018 Sep 12. pii: 10.1007/s10549-018-4966.
    PubMed     Text format     Abstract available

  17. OLIVA-MORENO J, Pena-Longobardo LM
    Labour productivity loss caused by premature deaths associated with breast cancer: results from Spain over a 10-year period.
    Breast Cancer Res Treat. 2018 Sep 12. pii: 10.1007/s10549-018-4963.
    PubMed     Text format     Abstract available


    Cancer Epidemiol Biomarkers Prev

  18. BOND-SMITH D, Stone J
    Methodological challenges and updated findings from a meta-analysis of the association between mammographic density and breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2018 Sep 11. pii: 1055-9965.EPI-17-1175.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  19. HAMMER J, Geinitz H, Nieder C, Track C, et al
    Risk Factors for Local Relapse and Inferior Disease-free Survival After Breast-conserving Management of Breast Cancer: Recursive Partitioning Analysis of 2161 Patients.
    Clin Breast Cancer. 2018 Aug 22. pii: S1526-8209(18)30241.
    PubMed     Text format     Abstract available

  20. CHEN X, Fan Y, Xu B
    Distinct Characteristics and Metastatic Behaviors of Late Recurrence in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2-negative Breast Cancer: A Single Institute Experience of More Than 10 Years.
    Clin Breast Cancer. 2018 Jul 24. pii: S1526-8209(18)30303.
    PubMed     Text format     Abstract available

  21. HAYASHI N, Tsunoda H, Namura M, Ochi T, et al
    Magnetic Resonance Imaging Combined With Second-look Ultrasonography in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Primary Breast Cancer Patients.
    Clin Breast Cancer. 2018 Aug 24. pii: S1526-8209(18)30234.
    PubMed     Text format     Abstract available


    Eur J Cancer

  22. VAN ROOIJEN JM, Qiu SQ, Timmer-Bosscha H, van der Vegt B, et al
    Androgen receptor expression inversely correlates with immune cell infiltration in human epidermal growth factor receptor 2-positive breast cancer.
    Eur J Cancer. 2018;103:52-60.
    PubMed     Text format     Abstract available


    Int J Cancer

  23. KOMEMI O, Epstein Shochet G, Pomeranz M, Fishman A, et al
    Placenta-conditioned extracellular matrix (ECM) activates breast cancer cell survival mechanisms: A key for future distant metastases.
    Int J Cancer. 2018 Sep 8. doi: 10.1002/ijc.31861.
    PubMed     Text format     Abstract available

  24. HAM SA, Kim E, Yoo T, Lee WJ, et al
    Ligand-activated interaction of PPARdelta with c-Myc governs the tumorigenicity of breast cancer.
    Int J Cancer. 2018 Sep 11. doi: 10.1002/ijc.31864.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  25. ZHANG L, Bochkur Dratver M, Yazal T, Dong K, et al
    Mebendazole potentiates radiation therapy in triple-negative breast cancer.
    Int J Radiat Oncol Biol Phys. 2018 Sep 6. pii: S0360-3016(18)33688.
    PubMed     Text format     Abstract available


    J Clin Invest

  26. WANG Y, Weng X, Wang L, Hao M, et al
    HIC1 deletion promotes breast cancer progression by activating tumor cell/fibroblast crosstalk.
    J Clin Invest. 2018 Sep 11. pii: 99974. doi: 10.1172/JCI99974.
    PubMed     Text format     Abstract available


    J Clin Oncol

  27. SEIDMAN AD, Bordeleau L, Fehrenbacher L, Barlow WE, et al
    National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer.
    J Clin Oncol. 2018 Sep 13:JCO1800242. doi: 10.1200/JCO.18.00242.
    PubMed     Text format     Abstract available


    J Surg Oncol

  28. SUSNIK B, Schneider L, Swenson KK, Krueger J, et al
    Predictive value of breast magnetic resonance imaging in detecting mammographically occult contralateral breast cancer: Can we target women more likely to have contralateral breast cancer?
    J Surg Oncol. 2018;118:221-227.
    PubMed     Text format     Abstract available


    Lancet Oncol

  29. KUERER HM
    More evidence for further minimisation of breast-cancer surgery.
    Lancet Oncol. 2018 Sep 5. pii: S1470-2045(18)30416.
    PubMed     Text format    

  30. GALIMBERTI V, Cole BF, Viale G, Veronesi P, et al
    Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
    Lancet Oncol. 2018 Sep 5. pii: S1470-2045(18)30380.
    PubMed     Text format     Abstract available


    Nat Rev Clin Oncol

  31. PONDE NF, Zardavas D, Piccart M
    Progress in adjuvant systemic therapy for breast cancer.
    Nat Rev Clin Oncol. 2018 Sep 11. pii: 10.1038/s41571-018-0089.
    PubMed     Text format     Abstract available


    NPJ Breast Cancer

  32. RAWAT RR, Ruderman D, Macklin P, Rimm DL, et al
    Correlating nuclear morphometric patterns with estrogen receptor status in breast cancer pathologic specimens.
    NPJ Breast Cancer. 2018;4:32.
    PubMed     Text format     Abstract available

  33. MAGBANUA MJM, Rugo HS, Hauranieh L, Roy R, et al
    Genomic and expression profiling reveal molecular heterogeneity of disseminated tumor cells in bone marrow of early breast cancer.
    NPJ Breast Cancer. 2018;4:31.
    PubMed     Text format     Abstract available


    Oncogene

  34. ZHANG DD, Li Y, Xu Y, Kim J, et al
    Phosphodiesterase 7B/microRNA-200c relationship regulates triple-negative breast cancer cell growth.
    Oncogene. 2018 Sep 12. pii: 10.1038/s41388-018-0499.
    PubMed     Text format     Abstract available


    PLoS One

  35. GONG IY, Fox NS, Huang V, Boutros PC, et al
    Prediction of early breast cancer patient survival using ensembles of hypoxia signatures.
    PLoS One. 2018;13:e0204123.
    PubMed     Text format     Abstract available

  36. TAN MM, Ho WK, Yoon SY, Mariapun S, et al
    A case-control study of breast cancer risk factors in 7,663 women in Malaysia.
    PLoS One. 2018;13:e0203469.
    PubMed     Text format     Abstract available

  37. LI G, Guo X, Chen M, Tang L, et al
    Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients.
    PLoS One. 2018;13:e0203495.
    PubMed     Text format     Abstract available

  38. YOO J, Kim BS, Chung J, Yoon HJ, et al
    Clinical value of delayed 18F-FDG PET/CT for predicting nipple-areolar complex involvement in breast cancer: A comparison with clinical symptoms and breast MRI.
    PLoS One. 2018;13:e0203649.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  39. WANG B, Li D, Kovalchuk I, Apel IJ, et al
    miR-34a directly targets tRNAi(Met) precursors and affects cellular proliferation, cell cycle, and apoptosis.
    Proc Natl Acad Sci U S A. 2018;115:7392-7397.
    PubMed     Text format     Abstract available


    Radiology

  40. OLIGANE HC, Berg WA, Bandos AI, Chen SS, et al
    Grouped Amorphous Calcifications at Mammography: Frequently Atypical but Rarely Associated with Aggressive Malignancy.
    Radiology. 2018 Jun 19:172406. doi: 10.1148/radiol.2018172406.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: